医薬品添加剤の世界市場の規模・成長率・動向分析：機能・用途・製品別の予測 (～2032年)

医薬品添加剤の市場規模は、2023年の92億7,000万米ドル、2024年の100億2,000万米ドルから、予測期間中は7.03％のCAGRで推移し、2032年には184億8,000万米ドルの規模に成長すると予測されています。

多機能添加剤へのニーズの高まりとジェネリック医薬品の使用の増加が、市場拡大の主な要因です。

医薬品添加剤は薬の風味を高めるためにも使用され、特に若い患者のコンプライアンスを高めています。医薬品添加剤は、その化学組成によって有機物と無機物の両方から得られます。機能性添加剤に対するニーズの高まり、最近の特許切れ、ナノテクノロジーの急速な進歩は、医薬品添加剤市場を推進する主な要因です。長期安定化、最終剤形における有効成分の効力増強、その他の目的のために、添加剤は少量の原薬を含む固形製剤に添加されます。さらに添加剤は、原薬の溶解度を高め、粘度を下げ、薬物吸収を改善するなど、医薬品製剤の特性を改善するためにも使用されます。

地域別展望

欧州の医薬品添加剤市場は、2022年に25億1,000万米ドルの規模を示し、大幅なCAGRで成長すると予測されています。医薬品特許の有効期限が近づいているため、多くの欧州諸国はジェネリック医薬品産業に注力しています。ドイツ、英国、フランスなどの欧州諸国が、予測期間中に顕著な成長率を示す見通しです。医薬品添加剤はこの地域でますます必要とされるようになると予想されています。

北米は医薬品添加剤市場で2番目に大きなシェアを占めています。予測期間中、製薬部門の急速な発展、機能性添加剤に対する需要の高まり、業界の有力企業の存在、技術の進歩などにより、市場は大幅に増加すると予想されます。

アジア太平洋地域の医薬品添加剤市場は、2024年から2032年にかけてもっとも速いCAGRで成長すると予測されています。

当レポートでは、世界の医薬品添加剤の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

• 概要
• 促進要因
• 抑制要因
• 機会

第5章 市場要因分析

• バリューチェーン分析
• ポーターのファイブフォース分析
• COVID-19の影響分析

第6章 世界の医薬品添加剤市場：タイプ別

• 概要
• 医薬品充填剤
• バインダー
• コーティング
• 崩壊剤
• 防腐剤
• その他

第7章 世界の医薬品添加剤市場：製品別

• 概要
• 有機化学品
• 無機化学品

第8章 世界の医薬品添加剤市場：用途別

• 概要
• 経口
• 局所
• 非経口
• その他

第9章 世界の医薬品添加剤市場：地域別

• 概要
• 北米
• 欧州
• アジア太平洋
• その他の地域

第10章 企業情勢

• 概要
• 競合分析
• 市場シェア分析
• 主な成長戦略
• 競合ベンチマーキング
• 開発数でリードする企業
• 主な展開・成長戦略
• 主要企業の財務マトリックス

第11章 企業プロファイル

• EVONIK INDUSTRIES AG
• BASF SE
• FERRO CORPORATION
• P&G CHEMICALS
• FMC CORPORATION
• THE DOW CHEMICAL COMPANY
• ASHLAND, INC.
• CRODA INTERNATIONAL PLC
• AKZO NOBEL NV
• INNOPHOS

第12章 付録

LIST OF TABLES

• TABLE 1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SYNOPSIS, 2019-2032
• TABLE 2 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD MILLION)
• TABLE 3 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 4 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 5 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 6 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2019-2032 (USD MILLION)
• TABLE 7 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 8 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 9 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 10 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 11 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 12 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 13 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 14 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 15 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 16 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 17 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY 2019-2032 (USD MILLION)
• TABLE 18 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 19 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 20 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 21 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 22 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 23 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 24 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 25 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 26 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 27 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 28 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 29 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 30 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 31 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 32 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 33 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 34 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 35 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 36 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 37 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 38 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 39 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 40 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 41 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 42 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 43 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 44 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 45 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 46 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 47 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 48 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 49 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 50 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 51 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 52 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 53 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 54 AUSTRALIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 55 AUSTRALIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 56 AUSTRALIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 57 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 58 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 59 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 60 REST OF ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 61 REST OF ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 62 REST OF ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 63 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY 2019-2032 (USD MILLION)
• TABLE 64 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 65 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 66 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 67 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 68 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 69 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 70 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 71 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 72 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 73 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 74 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 75 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)

LIST OF FIGURES

• FIGURE 1 RESEARCH PROCESS
• FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
• FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
• FIGURE 4 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY FUNCTION,
• FIGURE 5 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY PRODUCT,
• FIGURE 6 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY APPLICATION,
• FIGURE 7 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY REGION,
• FIGURE 8 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY,
• FIGURE 9 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY,
• FIGURE 10 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY,
• FIGURE 11 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY,
• FIGURE 12 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY SHARE ANALYSIS (%),
• FIGURE 13 EVONIK INDUSTRIES AG: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 14 EVONIK INDUSTRIES AG: SWOT ANALYSIS
• FIGURE 15 BASF SE: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 16 BASF SE: SWOT ANALYSIS
• FIGURE 17 P&G CHEMICALS: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 18 P&G CHEMICALS: SWOT ANALYSIS
• FIGURE 19 AKZO NOBEL NV, INC: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 20 AKZO NOBEL NV, INC: SWOT ANALYSIS
• FIGURE 21 FMC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 22 FMC CORPORATION: SWOT ANALYSIS
• FIGURE 23 THE DOW CHEMICAL COMPANY: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 24 THE DOW CHEMICAL COMPANY: SWOT ANALYSIS
• FIGURE 25 ASHLAND, INC.: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 26 ASHLAND, INC.: SWOT ANALYSIS
• FIGURE 27 CRODA INTERNATIONAL PLC: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 28 CRODA INTERNATIONAL PLC: SWOT ANALYSIS
• FIGURE 29 FERRO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 30 FERRO CORPORATION: SWOT ANALYSIS
• FIGURE 31 INNOPHOS: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 32 INNOPHOS: SWOT ANALYSIS

Global Pharmaceutical Excipients Market Size, Growth and Trends Analysis by Function (Pharmaceutical Fillers, Binders, Coatings, Disintegrants, Preservatives, Others), Application (Oral, Parenteral, Topical, Others), Product (Organic Chemicals, Inorganic Chemicals) - Industry Forecast 2032

Market Snapshot

The size of the pharmaceutical excipients market was estimated at USD 9.27 billion in 2023 and is expected to increase at a compound annual growth rate (CAGR) of 7.03% from 2024 to 2032, from USD 10.02 billion in 2024 to USD 18.48 billion by 2032. The growing need for multifunctional excipients and the growing use of generic drugs are the primary factors propelling market expansion.

Furthermore, the market for pharmaceutical excipients is used to enhance the medication's flavor, which increases patient compliance, especially in young patients. Pharmaceutical excipients can come from both organic and inorganic sources, depending on their chemical composition. The growing need for functional excipients, recent patent expirations that increase consumer demand for pharmaceutical excipients, and the rapid advancement of nanotechnology are the primary factors propelling the pharmaceutical excipients market. For long-term stabilization, to increase the potency of the active ingredient in the final dosage form, or for any other purpose, excipients can be added to solid formulations that contain small APIs. Additionally, excipients are used to improve the properties of medicinal formulations, including increasing API solubility, decreasing viscosity, and improving drug absorption.

Market Segments Insights

Pharmaceutical fillers, binders, coatings, disintegrants, preservatives, and others are among the market sectors for pharmaceutical excipients based on their operational roles.

By-products have been separated into organic and inorganic compounds according to market data for pharmaceutical excipients.

The pharmaceutical excipients market has been divided into several segments based on applications, including parenteral, topical, and oral.

Regional Perspectives

The market insights by region in the survey encompass Asia-Pacific, Europe, North America, and the rest of the globe. The pharmaceutical excipients market in Europe was estimated to be worth USD 2.51 billion in 2022 and was projected to grow at a significant compound annual growth rate. Many European nations concentrate on the generics industry because of the approaching expiration dates of pharmaceutical patents. Therefore, it is expected that European nations such as Germany, the United Kingdom, France, and others will have notable growth rates over the forecast period. Pharmaceutical excipients are expected to become more and more necessary in the region.

North America has the second-largest proportion of the pharmaceutical excipients market. Over the course of the projection period, the market is expected to increase significantly due to the quickly increasing pharmaceutical sector, rising demand for functional excipients, strong competitors in the industry, and technological advancements.

The Asia-Pacific pharmaceutical excipients market is projected to grow at the fastest compound annual growth rate (CAGR) from 2024 to 2032. According to a recent study, China's overall revenue from traditional pharmaceutical sales is expected to increase over the coming years.

Key Players

Evonik Industries Ag, Basf Se, Ferro Corporation, P&G Chemicals, Akzo Nobel NV, FMC Corporation, The Dow Chemical Company, Ashland, Inc., and Croda International PLC are a few of the major players in the pharmaceutical excipients industry.

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

• 2.1. DEFINITION
• 2.2. SCOPE OF THE STUDY
  • 2.2.1. RESEARCH OBJECTIVE
  • 2.2.2. ASSUMPTIONS
  • 2.2.3. LIMITATIONS

3. RESEARCH METHODOLOGY

• 3.1. OVERVIEW
• 3.2. DATA MINING
• 3.3. SECONDARY RESEARCH
• 3.4. PRIMARY RESEARCH
  • 3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • 3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5. FORECASTING TECHNIQUE
• 3.6. MARKET SIZE ESTIMATION
  • 3.6.1. BOTTOM-UP APPROACH
  • 3.6.2. TOP-DOWN APPROACH
• 3.7. DATA TRIANGULATION
• 3.8. VALIDATION

4. MARKET DYNAMICS

• 4.1. OVERVIEW
• 4.2. DRIVERS
• 4.3. RESTRAINTS
• 4.4. OPPORTUNITIES

5. MARKET FACTOR ANALYSIS

• 5.1. VALUE CHAIN ANALYSIS
• 5.2. PORTER'S FIVE FORCES ANALYSIS
  • 5.2.1. BARGAINING POWER OF SUPPLIERS
  • 5.2.2. BARGAINING POWER OF BUYERS
  • 5.2.3. THREAT OF NEW ENTRANTS
  • 5.2.4. THREAT OF SUBSTITUTES
  • 5.2.5. INTENSITY OF RIVALRY
• 5.3. COVID-19 IMPACT ANALYSIS
  • 5.3.1. MARKET IMPACT ANALYSIS
  • 5.3.2. REGIONAL IMPACT
  • 5.3.3. OPPORTUNITY AND THREAT ANALYSIS

6. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE

• 6.1. OVERVIEW
• 6.2. PHARMACEUTICAL FILLERS
• 6.3. BINDERS
• 6.4. COATINGS
• 6.5. DISINTEGRANTS
• 6.6. PRESERVATIVES
• 6.7. OTHERS

7. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT

• 7.1. OVERVIEW
• 7.2. ORGANIC CHEMICALS
• 7.3. INORGANIC CHEMICALS

8. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION

• 8.1. OVERVIEW
• 8.2. ORAL
• 8.3. TOPICAL
• 8.4. PARENTERAL
• 8.5. OTHERS

9. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION

• 9.1. OVERVIEW
• 9.1. NORTH AMERICA
  • 9.1.1. US
  • 9.1.2. CANADA
• 9.2. EUROPE
  • 9.2.1. GERMANY
  • 9.2.2. FRANCE
  • 9.2.3. UK
  • 9.2.4. ITALY
  • 9.2.5. SPAIN
  • 9.2.6. REST OF EUROPE
• 9.3. ASIA-PACIFIC
  • 9.3.1. CHINA
  • 9.3.2. INDIA
  • 9.3.3. JAPAN
  • 9.3.4. SOUTH KOREA
  • 9.3.5. AUSTRALIA
  • 9.3.6. REST OF ASIA-PACIFIC
• 9.4. REST OF THE WORLD
  • 9.4.1. MIDDLE EAST
  • 9.4.2. AFRICA
  • 9.4.3. LATIN AMERICA

10. COMPANY LANDSCAPE

• 10.1. OVERVIEW
• 10.2. COMPETITIVE ANALYSIS
• 10.3. MARKET SHARE ANALYSIS
• 10.4. MAJOR GROWTH STRATEGY IN THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
• 10.5. COMPETITIVE BENCHMARKING
• 10.6. LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
• 10.7. KEY DEVELOPMENTS AND GROWTH STRATEGIES
  • 10.7.1. NEW PRODUCT LAUNCH
  • 10.7.2. MERGER & ACQUISITIONS
  • 10.7.3. JOINT VENTURES
• 10.8. MAJOR PLAYERS FINANCIAL MATRIX
  • 10.8.1. SALES & OPERATING INCOME,
  • 10.8.2. MAJOR PLAYERS R&D EXPENDITURE.

11. COMPANY PROFILES

• 11.1. EVONIK INDUSTRIES AG
  • 11.1.1. COMPANY OVERVIEW
  • 11.1.2. FINANCIAL OVERVIEW
  • 11.1.3. PRODUCT OFFERED
  • 11.1.4. KEY DEVELOPMENTS
  • 11.1.5. SWOT ANALYSIS
  • 11.1.6. KEY STRATEGIES
• 11.2. BASF SE
  • 11.2.1. COMPANY OVERVIEW
  • 11.2.2. FINANCIAL OVERVIEW
  • 11.2.3. PRODUCT OFFERED
  • 11.2.4. KEY DEVELOPMENTS
  • 11.2.5. SWOT ANALYSIS
  • 11.2.6. KEY STRATEGIES
• 11.3. FERRO CORPORATION
  • 11.3.1. COMPANY OVERVIEW
  • 11.3.2. FINANCIAL OVERVIEW
  • 11.3.3. PRODUCT OFFERED
  • 11.3.4. KEY DEVELOPMENTS
  • 11.3.5. SWOT ANALYSIS
  • 11.3.6. KEY STRATEGIES
• 11.4. P&G CHEMICALS
  • 11.4.1. COMPANY OVERVIEW
  • 11.4.2. FINANCIAL OVERVIEW
  • 11.4.3. PRODUCT OFFERED
  • 11.4.4. KEY DEVELOPMENTS
  • 11.4.5. SWOT ANALYSIS
  • 11.4.6. KEY STRATEGIES
• 11.5. FMC CORPORATION
  • 11.5.1. COMPANY OVERVIEW
  • 11.5.2. FINANCIAL OVERVIEW
  • 11.5.3. PRODUCT OFFERED
  • 11.5.4. KEY DEVELOPMENTS
  • 11.5.5. SWOT ANALYSIS
  • 11.5.6. KEY STRATEGIES
• 11.6. THE DOW CHEMICAL COMPANY
  • 11.6.1. COMPANY OVERVIEW
  • 11.6.2. FINANCIAL OVERVIEW
  • 11.6.3. PRODUCT OFFERED
  • 11.6.4. KEY DEVELOPMENTS
  • 11.6.5. SWOT ANALYSIS
  • 11.6.6. KEY STRATEGIES
• 11.7. ASHLAND, INC.
  • 11.7.1. COMPANY OVERVIEW
  • 11.7.2. FINANCIAL OVERVIEW
  • 11.7.3. PRODUCT OFFERED
  • 11.7.4. KEY DEVELOPMENTS
  • 11.7.5. SWOT ANALYSIS
  • 11.7.6. KEY STRATEGIES
• 11.8. CRODA INTERNATIONAL PLC
  • 11.8.1. COMPANY OVERVIEW
  • 11.8.2. FINANCIAL OVERVIEW
  • 11.8.3. PRODUCT OFFERED
  • 11.8.4. KEY DEVELOPMENTS
  • 11.8.5. SWOT ANALYSIS
  • 11.8.6. KEY STRATEGIES
• 11.9. AKZO NOBEL NV
  • 11.9.1. COMPANY OVERVIEW
  • 11.9.2. FINANCIAL OVERVIEW
  • 11.9.3. PRODUCT OFFERED
  • 11.9.4. KEY DEVELOPMENTS
  • 11.9.5. SWOT ANALYSIS
  • 11.9.6. KEY STRATEGIES
• 11.10. INNOPHOS
  • 11.10.1. COMPANY OVERVIEW
  • 11.10.2. FINANCIAL OVERVIEW
  • 11.10.3. PRODUCT OFFERED
  • 11.10.4. KEY DEVELOPMENTS
  • 11.10.5. SWOT ANALYSIS
  • 11.10.6. KEY STRATEGIES

12. APPENDIX

• 12.1. REFERENCES
• 12.2. RELATED REPORTS